Literature DB >> 25933141

Mycophenolate-Induced Posterior Reversible Encephalopathy Syndrome.

Bhavik Khajuria1, Mansi Khajuria, Yashwant Agrawal.   

Abstract

A 29-year-old woman presented with diffuse anasarca and shortness of breath. Workup revealed a creatinine of 3.3 and a glomerular filtration rate of 17. The patient was also found to be pancytopenic with evidence of hemolytic anemia. A renal biopsy showed evidence of stage IV lupus nephritis with rapidly progressive glomerulonephritis. Her lupus was further classified as ANA negative and anti-dsDNA positive. Mycophenolate and triweekly hemodialysis were started along with a steroid burst of methylprednisolone 1 g for 3 days followed by prednisone 60 mg daily. Four days after discharge, the patient represented with a witnessed 3-minute seizure involving bowel incontinence, altered mental status, and tongue biting. She was given 2 mg intravenous lorazepam and loaded with 1000 mg levetiracetam for seizure prophylaxis. Magnetic resonance imaging of the head revealed bilateral posterior hemispheric subcortical edema, and the diagnosis of posterior reversible encephalopathy syndrome was made. Mycophenolate was immediately discontinued and replaced with cyclophosphamide. Strict blood pressure control below 140/90 mm Hg was maintained initially with intravenous nicardipine drip and then transitioned to oral nifedipine, clonidine, losartan, and minoxidil. A repeat head magnetic resonance imaging 8 days later showed resolved subcortical edema consistent with the patient's improved mental status. No permanent neurologic sequelae were recorded as a result of this hospital episode.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 25933141     DOI: 10.1097/MJT.0000000000000270

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  5 in total

1.  Posterior reversible encephalopathy syndrome (PRES) attributed to mycophenolate mofetil during the management of SLE: a case report and review.

Authors:  Lei Zhang; Jian Xu
Journal:  Am J Clin Exp Immunol       Date:  2018-02-05

Review 2.  Neurological Complications in Patients with Systemic Lupus Erythematosus.

Authors:  Amir Shaban; Enrique C Leira
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 6.030

3.  Clinico-radiological Profile of Posterior Reversible Encephalopathy Syndrome and Its Associated Risk Factors in PICU: A Single-center Experience from a Tertiary Care Hospital in Bhubaneswar, Odisha.

Authors:  Chinmay K Behera; Mukesh K Jain; Reshmi Mishra; Pratap K Jena; Santosh K Dash; Ranjan K Sahoo
Journal:  Indian J Crit Care Med       Date:  2020-12

4.  Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.

Authors:  Sushil Khanal; Rohit Kumar Chaudhary; Kripa Kc; Supriya Lamichhane; Sarita Kathayat; Subash Prasad Acharya
Journal:  Ann Med Surg (Lond)       Date:  2021-02-05

5.  Escalation to Barbiturate-Induced Coma for Refractory Seizures after Liver Transplantation.

Authors:  Brittany Miles; Muhammad Mujtaba; Shehzad Merwat; Rupak Kulkarni; Jeffrey Fair; Michael Kueht
Journal:  Case Reports Hepatol       Date:  2022-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.